$GALE Headlines Top longs and shorts to watch 12:18 p.m.

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
$GALE Headlines

Top longs and shorts to watch 12:18 p.m. March 6, 2012 - The Trading Deck

4 Reasons Why Galena Biopharma Is Headed Higher 1:05 p.m. Dec. 4, 2013 - Wall St. Cheat Sheet
Perilous Reversal Stock: Galena Biopharma (GALE) 11:40 a.m. Dec. 3, 2013 - TheStreet.com
Galena rallies, article calls pipeline "rich" 11:31 a.m. Dec. 2, 2013 - Seeking Alpha
Biotech Stocks Partying Like It's 1999 7:00 a.m. Dec. 2, 2013 - TheStreet.com
Galena: A Pipeline Rich For Investors 2:46 a.m. Dec. 2, 2013 - Seeking Alpha
2 Team Alpha Portfolio Updates: Selling Several Losing Positions And Performance Reviews 1:37 a.m. Dec. 2, 2013 - Seeking Alpha
Biotech Stocks With Promise 11:00 a.m. Nov. 29, 2013 - RealMoney.com
Interesting GALE Put And Call Options For July 2014 10:45 a.m. Nov. 27, 2013 - TheStreet.com
Galena: More Reasons To Buy 7:59 a.m. Nov. 27, 2013 - Seeking Alpha
Healthcare upgrades, downgrades, and initiations for Tuesday 12:48 p.m. Nov. 26, 2013 - Seeking Alpha
Galena Biopharma jumps on Oppenheimer initiation seeing 63% upside 10:24 a.m. Nov. 26, 2013 - Seeking Alpha
Trade-Ideas: Galena Biopharma (GALE) Is Today's "Dead Cat Bounce" Stock 10:06 a.m. Nov. 26, 2013 - TheStreet.com
Top Analyst Upgrades and Downgrades: FireEye, Fresh Market, Galena, Peabody and More 8:04 a.m. Nov. 26, 2013 - 247WallSt.com
UPDATE: Oppenheimer Initiates Coverage on Galena Biopharma on NeuVax/Abstral Potential 7:41 a.m. Nov. 26, 2013 - benzinga.com
Galena Biopharma (GALE) In A Perilous Reversal 9:45 a.m. Nov. 25, 2013 - TheStreet.com
Monday’s Biggest Stock Losers: FB, ADT, and More 5:11 a.m. Nov. 25, 2013 - InvestorPlace.com
Monday’s Biggest Stock Losers: FB, ADT, and More 5:11 a.m. Nov. 25, 2013 - InvestorPlace.com
The Young And Restless Portfolio Has Had Spectacular Gains, Is It Time To Sell? 3:18 a.m. Nov. 24, 2013 - Seeking Alpha
Galena Biopharma: Luck Favors The Unprepared 5:11 p.m. Nov. 23, 2013 - Seeking Alpha
January 2016 Options Now Available For Galena Biopharma (GALE) 11:17 a.m. Nov. 22, 2013 - TheStreet.com


TrendingWallStreet.com Begins Volume Coverage on FB, TC, OCZ, and GALE 12:21 a.m. Dec. 5, 2013 - ACCESSWIRE
Breakfast News: Hewlett-Packard Company, Alpha Natural Resources, Yahoo! Inc, Galena Biopharma 8:51 a.m. Dec. 4, 2013 - ACCESSWIRE
Corporate News, Acquisitions: Herbalife Ltd, 3D Systems Corporation, Federal National Mortgage Association, Galena Biopharma Inc, Oncomed Pharmaceuticals 8:44 a.m. Dec. 4, 2013 - PR Newswire
Galena Biopharma to Present at the Oppenheimer 24th Annual Healthcare Conference 7:05 a.m. Dec. 4, 2013 - GlobeNewswire
Healthcare Sector Announce Awards, Conference Participation, Partnerships, and Closure of Public Offering - Research Report on Regeneron, Alnylam, Galena Biopharma, Amedisys, and Aeterna Zentaris 8:00 a.m. Dec. 3, 2013 - PR Newswire
TrendingWallStreet.com Begins Volume Coverage on MYGN, FNMA, ABX, and GALE 12:26 a.m. Dec. 3, 2013 - ACCESSWIRE
Pre-Market Breakdown: Galena Biopharma Inc., Novavax Inc., Ariad Pharma Inc., and MannKind Corp. 8:00 a.m. Nov. 27, 2013 - PR Newswire
Galena Biopharma to Present at the 25th Annual Piper Jaffray Healthcare Conference 7:05 a.m. Nov. 26, 2013 - GlobeNewswire
HIMX, GALE, INTC and NVGN added to NASDAQ Active Stock Watch List at GSR 10:16 a.m. Nov. 25, 2013 - ACCESSWIRE
Settlement Agreement, Presentation of Trial Results, and Stock Price Update - Research Report on Johnson & Johnson, Mettler-Toledo, Galena Biopharma, Dendreon, and Amedisys 8:00 a.m. Nov. 25, 2013 - PR Newswire
Quarterly Reports and Events - Research Report on Mettler-Toledo, Galena Biopharma, Achillion, Wright Medical, and OXiGENE 8:00 a.m. Nov. 15, 2013 - PR Newswire
ZLCS, CLRX, DSCO and GALE added to NASDAQ Active Stock Watch List at GSR 10:19 a.m. Nov. 11, 2013 - ACCESSWIRE
Galena Biopharma Announces Initial Results From the Folate Binding Protein Vaccine Phase 1 Trial at the Society for Immunotherapy of Cancer Conference 7:05 a.m. Nov. 11, 2013 - GlobeNewswire
Galena Biopharma Reports Third Quarter 2013 Results 4:35 p.m. Nov. 6, 2013 - GlobeNewswire
Closing of Over-Allotment Options, Receiving Orphan Drug Designations, Release of Clinical Data, and Obtaining Important Patents - Research Report on Galena, Zalicus, Infinity, Stemline and Insmed 8:00 a.m. Nov. 5, 2013 - PR Newswire
Morning Research: Ariad Pharma Inc., MannKind Corp., Novavax Inc., and Galena Biopharma Inc. 1:30 p.m. Nov. 1, 2013 - PR Newswire
New Small Cap Reports on RXII, APPA and TRTC 2:20 a.m. Nov. 1, 2013 - ACCESSWIRE
3 Reasons To Consider Investing In RXi Pharmaceuticals 10:17 a.m. Oct. 16, 2013 - ACCESSWIRE
Mentor Capital Cancer Immunotherapy Index Up 100% in 2013 8:03 a.m. Oct. 16, 2013 - BusinessWire
Pre-Market Review: MannKind Corp., Galena Biopharma Inc., Ariad Pharmaceuticals Inc., and Novavax Inc. 3:40 p.m. Oct. 10, 2013 - PR Newswire

Scroll down for more posts ▼

Top 10 Most Recent News Articles

CACI Hits $50K Milestone in Service Dog Program

Updated Category News Views 13

Ice Blocking for a Noble Cause Last I checked, mixing the adrenaline of ice hockey with the grit of veteran support isn't your typical skate on thin ice. But CACI International Inc (NYSE:CACI), with their Good Dogs for Great Americans program, is doing just that. They're taking every blocked shot by the Washington Capitals and turning it into a stepping stone for veterans...

Continue Reading
Jacquie Lawson's Advent Calendar Delights Fans for 17th Year

Updated Category News Views 63

A Festive Tradition with a Twist The Jacquie Lawson Advent calendar is back for its 17th season, and it's no ho-hum affair. This time, the scene is set against the breathtaking backdrop of England's Lake District. If you've been yearning for a bit of that classic literary and natural charm, this is your ticket—minus the airfare. The calendar isn't just a countdown; it's...

Continue Reading
LifeStance Expands Access to Esketamine, TMS

Updated Category News Views 87

LifeStance Health's Treatment Innovations Today, the spotlight is on LifeStance Health, as they're making waves with their treatment approaches for those battling stubborn, treatment-resistant depression. This isn't your run-of-the-mill attempt at tackling the beast—that familiar indifference masked as hope. No, this time around, they’re swinging with Esketamine and...

Continue Reading
OCI Cleared to Merge with Orascom, Sets Delisting Date

Updated Category News Views 117

OCI N.V. has hit a milestone. The shareholders have given the green light to merge with Orascom Construction PLC. This move is fleshed out with an updated roadmap that sharp-eyed investors need to watch closely. The company's shares will no longer be trading on Euronext Amsterdam by late November 2026, contingent on regulatory nods and other variables swirling in the...

Continue Reading
Sentral Expands: Fort Lauderdale & San Diego Additions

Updated Category News Views 112

Sentral's Strategic Leap into New Markets Ever heard of a company spreading its wings like wildfire? That’s Sentral for you, crashing into Fort Lauderdale and pushing deeper roots in San Diego. We’re not talking minor plays here—these two fresh additions make Sentral a resident-giant stretched across 22 markets. Seems like they’re on a mission to ink their mark...

Continue Reading
Lecanemab's New Data: What Investors Should Monitor

Updated Category News Views 35

Lecanemab: A Bold Step in Alzheimer's Treatment? Investors eyeing the biotech sector should pay close attention to the upcoming CTAD conference in 2026, where BioArctic AB's partner, Eisai, is set to present fresh data on lecanemab (Leqembi®). This isn't just another pharma front-page story—this is about potential breakthroughs in Alzheimer's treatment that's caught...

Continue Reading
WhiteFiber's Q3 2026 Call: Key Insights Await Investors

Updated Category News Views 51

Eyes on WhiteFiber's Upcoming Earnings Call You know the drill—results call season can make or break some days for us investors. WhiteFiber, Inc. (NASDAQ: WYFI) is gearing up for their third-quarter earnings call on November 10, 2026, at 9:00 a.m. Eastern Time. As a player in the AI infrastructure game, expectations ride high. With their networks and data centers...

Continue Reading
Kansas City Life's Q3: Earnings Dip, but Growth Ahead

Updated Category News Views 0

Striking a Balance: Kansas City Life's Q3 They say numbers don’t lie, and Kansas City Life Insurance just shared their latest. This quarter, things weren't all smooth sailing, but there's a silver lining. For Q3 2026, net income clocked in at $1.7 million, or $0.18 per share, down from last year’s $2.8 million, or $0.29 per share. Sure, it wasn't all sunshine and...

Continue Reading
Shareholder Stakes at Risk in Major Mergers

Updated Category News Views 15

Deals in the Spotlight: What's at Stake? Ever wonder if you're getting the short end of the stick while company insiders walk away with the spoils? That's the song and dance investors face with the likes of ADT Inc., Instacart, and MidCap Financial Investment Corporation lately. If you're wearing the shareholder hat, you might want to tune into the noise around these...

Continue Reading
Hehe Culture's Timeless Wisdom Explored at Forum

Updated Category News Views 39

Hehe Forum: Bridging the Past and Present Sometimes, the past isn't just anchor weight, it's a compass guiding us through the murky waters of today. The Hehe Culture Forum's latest gathering in Tiantai County, Zhejiang Province, aimed to unravel just how much ancient wisdom can still steer the course in this fast-changing world. Delegates from 23 nations joined forces,...

Continue Reading

Top 5 Most Recently Viewed Articles

Chart Industries Transitions to New Leadership in Upcoming Merger

Updated Category News Views 242

Chart Industries Announces Leadership Change Chart Industries (NYSE: GTLS) is taking significant steps toward a future transition as CEO Jill Evanko has announced plans to assume a senior advisor role starting in early 2026. This change comes as she prepares to take on a new executive opportunity within a privately owned company. Evanko has been essential in steering the...

Continue Reading
Cornish Metals Expands South Crofty Tin Project Operations

Updated Category News Views 287

Cornish Metals Expands Land Financing at South Crofty Tin Project Cornish Metals Inc. (AIM/TSX-V: CUSN), a dedicated mineral exploration and development company, proudly reports an increase in its land ownership at the South Crofty tin project. This significant acquisition involves approximately 4.5 acres from Cornwall Council, enhancing direct access to the vital...

Continue Reading
Pacific Nations Cup 2025 Set for Exciting Semi-Finals in Denver

Updated Category News Views 663

Exciting Semi-Finals of the Pacific Nations Cup 2025 World Rugby has unveiled the schedule for the much-anticipated Pacific Nations Cup 2025 (PNC). This prestigious tournament will unfold against the backdrop of the iconic DICK'S Sporting Goods Park, bringing together six elite teams for a day filled with high-stakes rugby action. Host City: Denver Denver will serve as...

Continue Reading
Record-Breaking Achievements by AskGamblers Complaint Service

Updated Category News Views 127

Remarkable Achievement of AskGamblers Casino Complaint Service AskGamblers Casino Complaint Service (AGCCS) has reached an impressive milestone, successfully resolving complaints and returning over $80 million to players globally. This dedicated service is a vital part of AskGamblers, which is committed to ensuring fair treatment for online casino users. Recent Success in...

Continue Reading
Important Update for Treace Medical Investors: Join Action

Updated Category News Views 384

Join the Class Action Suit Against Treace Medical Concepts Attention to all shareholders of Treace Medical Concepts, Inc. (NASDAQ: TMCI): an essential opportunity to register for a class action lawsuit is now open. This announcement from The Gross Law Firm urges you to take action if you purchased shares of TMCI during the designated class period. Why You Should Consider...

Continue Reading